Small-cap technology names moved on a mix of deal financing, patent strategy and contract wins today. Anemoi's pre-RTO fundraising headlined the session, while Light Science Technologies revealed a harder first half offset by acquisition-driven momentum, and Tpximpact added another government contract to its order book.
Anemoi secures $3.2m ahead of Trasna reverse takeover
Anemoi (AIM:AMOI), the AIM-listed cash shell, has locked in $3.2m of advance subscription agreements as it works toward completing its previously announced reverse takeover of Trasna Solutions Technologies. Shares rose 11.111% to 1.6p as the market welcomed the funding, which arrives while the enlarged group, to be renamed Trasna on completion, remains a private target awaiting formal integration into the listed structure.
Of the total raised, $2.2m is earmarked to fund Trasna's growth and will convert into equity in the enlarged company at a 20% discount to RTO pricing once the deal closes. A further $1m stays with Anemoi itself as working capital, carrying identical discount terms but converting into AMOI shares rather than Trasna stock. Crucially, both tranches include downside protection: if the RTO fails to complete, the advances convert instead into shares of the respective company that received them, Trasna Solutions Technologies for the larger tranche, Anemoi for the smaller one, rather than disappearing as sunk cost.
"I am pleased to report that the proposed Trasna RTO is progressing apace and, while there is always execution risk, I am confident that the prospects for completion by the end of Q3/2026 or early Q4/2026 remain realistic," said Duncan Soukup, Chairman, Anemoi.
The structure matters as much as the sum. By giving both companies working capital now, while building in a conversion fallback tied to whichever entity ultimately holds the funds, Anemoi has effectively de-risked the bridge period for subscribers without diluting existing shareholders ahead of the RTO's completion. That said, the deal remains conditional on shareholder and regulatory approval materialising within the chairman's stated Q3-to-early-Q4 2026 window; a slip beyond that horizon would leave the cash shell structure, and its investors, in limbo for longer than the market has currently priced in.
Light Science Technologies revenue falls, but second half rebound builds
Light Science Technologies Holdings (AIM:LST), the fire safety and food security-focused technology and manufacturing group, reported revenue of £3.73m for the six months to 31 May, down from £5.06m a year earlier, with shares falling 9.375% to 1.45p on the update. The group swung to an adjusted operating loss of £0.69m, excluding £0.08m of exceptional acquisition costs, against a £0.04m operating profit in the same period last year, as gross margin slipped to 30.5% from 36.3%.
The shortfall traces to two specific drags: delayed project approvals at the Building Safety Regulator held back conversion in the passive fire protection division, while the contract electronics manufacturing arm lost momentum as a key product reached end-of-life for its largest pest control customer. Against that backdrop, the company raised £6.6m gross (£6.1m net) during the period to fund three acquisitions, the most significant being RLUK Injection, owner of the Injectaclad fire barrier system, completed on 14 April. Total group cash and undrawn facilities stood at £2.72m at period end.
"The strong end to H1 and strong momentum carried into the current period underpins management's confidence in a substantially stronger second half," said Simon Deacon, Chief Executive. The acquisitions reshape the earnings base going into H2, but they also mean the current share price reaction reflects a market weighing near-term margin pressure against a strategic bet that regulatory delays and product transitions prove temporary rather than structural.
Ethernity flags potential upside from patent licensing push
Ethernity Networks (AIM:ENET), the semiconductor technology supplier for networking appliances, said early feedback from its patent-monetisation process points toward both upfront licensing proceeds and ongoing revenue in future years. Shares rose 8.333% to 0.0013p as the company disclosed progress on a process first flagged alongside its 2025 annual results, under which it engaged an intellectual property brokerage to evaluate licensing opportunities across its patent portfolio.
Ethernity and its advisers say they have found evidence that multiple vendors across the AI infrastructure and telecommunications markets may be using technology covered by its patents, and that these vendors collectively represent a substantial share of the relevant market, a factor the company believes strengthens the portfolio's commercial value. The group is still weighing its options, which could range from direct licensing agreements with the identified vendors to other commercial or legal routes, and cautioned that no transaction is guaranteed.
For a company of Ethernity's scale, a credible patent-licensing revenue stream would represent a materially different economic model than product sales alone, converting intellectual property into a recurring royalty base rather than one-off hardware or software deals. The caveat on execution is real, but the disclosure signals management sees enough substance in the vendor evidence to bring the process into public view now rather than wait for signed agreements.
Haleon prices $2bn bond to refinance 2027 notes
Haleon (LSE:HLN), the consumer health group behind Sensodyne and Panadol, has priced a $2bn three-tranche bond offering split across 2029, 2031 and 2036 maturities, with shares nudging up 0.06% to 357.7p. Proceeds, together with cash on hand, will fund the repurchase of Haleon's outstanding $2bn 3.375% senior notes due March 2027, following the tender offer the company launched on 11 August.
The new notes carry coupons of 4.625% on the $600m 2029 tranche, 4.875% on the $600m 2031 tranche, and 5.375% on the $800m 2036 tranche, with principal and interest fully and unconditionally guaranteed by Haleon Any proceeds beyond what is needed for the tender offer will go toward general corporate purposes across the group. Barclays Capital, BofA Securities, Deutsche Bank Securities, Goldman Sachs and Mizuho Securities acted as joint book-running managers.
The refinancing pushes out Haleon's nearest major debt maturity by two years at minimum while locking in coupons well above the 3.375% rate on the notes being retired, reflecting the higher-rate environment since those bonds were issued. The move is routine balance-sheet management rather than a signal of strategic change, but it removes a 2027 refinancing overhang from the group's capital structure well in advance.
TPXimpact lands £25m Ministry of Justice contract
Tpximpact Holdings (AIM:TPX) has been named successful bidder on a three-year probation digital delivery contract with the Ministry of Justice worth £25m, even as its shares fell 3.84% to 73.32p on the day. The win takes new business secured so far this financial year to £58m.
The contract adds meaningful revenue visibility over a three-year horizon and reinforces Tpximpact's positioning within UK public sector digital transformation work, a segment the company has leaned on for recurring, longer-cycle engagements. The share price move suggests the market's attention lies elsewhere today, but the contract award itself strengthens the order book underpinning near-term forecasts.
